Everyday Health on MSN

Quitting Zepbound Leads to at Least 25 Percent Weight Regain After a Year

Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, and other health metrics.

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...
Devdiscourse

Booming Weight-Loss Market and Legal Battles in Health News

The health sector witnesses significant developments with Eli Lilly's promising weight-loss drug trials and a $40 million ...

Weight-loss drugs fill a treatment gap for women with hormone disorder PCOS, doctors say

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

Lilly’s experimental shot reduces body weight by 23% in study

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight loss medicine yet.

Biotech boss urges pharma to move on from ‘weight-loss Olympics’

Pharma companies need to move beyond the “weight loss Olympics” and focus on more durable treatments with fewer side effects, ...
KVIA

Ozempic face: The cosmetic concerns of rapid weight loss

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...